VRK3 and Alzheimer disease: To determine whether VRK3-mediated HSP70 nuclear localization and subsequent downregulation of ERK activation defend against proteolytic stress by reducing aggregate toxicity, we examined prefrontal cortex sections from AD patients (Fig. 6c, Supplementary Table S2).